Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 145 No. 0304 (2015)

“When I’m rushing on my run” – novel psychoactive substances

  • Marc Walter
  • Undine E Lang
DOI
https://doi.org/10.4414/smw.2015.14091
Cite this as:
Swiss Med Wkly. 2015;145:w14091
Published
11.01.2015

References

  1. Nordt C, Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet. 2006;367(9525):1830–4.367: 1830–4.
  2. Liechti M. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling. Swiss Med Wkly. 2015;145:w14043 http://www.smw.ch/content/smw-2015-14043
  3. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35(1):217–38.
  4. Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564–74.
  5. Spaderna M, Addy PH, D’Souza DC. Spicing things up: synthetic cannabinoids. Psychopharmacology (Berl). 2013;228(4):525–40.
  6. Maxwell JC. Psychoactive substances – some new, some old: a scan of the situation in the U.S. Drug Alcohol Depend. 2014;134:71–7.

Most read articles by the same author(s)